Stephen Lazaroff, DPM
Podiatrist · Waterbury, CTNPI 1588084362
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 48 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Gramercy Extremity Orthopedics LLC at 35.3% of the total. Reporting peaked in 2019 at $925 and has fallen 65.2% since, to $322 in 2025.
Across 48 payments — averaging $71.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gramercy Extremity Orthopedics LLC$1K
- Smith+Nephew$855
- Celularity Inc.$259
- Organogenesis Inc.$185
- Orthofix Medical, Inc.$178
- Gotham Surgical Solutions & Devices, Inc.$144
- plus $594 from 7 others
Across 7 payments — averaging $7142.86 each. An ownership or investment interest held by the physician or an immediate family member.
- Gramercy Extremity Orthopedics LLC$50K
What the payments were for
- Food & beverage$3,424100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gramercy Extremity Orthopedics LLC | 7 | $1,210 |
| Smith+Nephew | 17 | $855 |
| Celularity Inc. | 3 | $259 |
| Organogenesis Inc. | 7 | $185 |
| Orthofix Medical, Inc. | 2 | $178 |
| Gotham Surgical Solutions & Devices, Inc. | 1 | $144 |
| Osiris Therapeutics Inc. | 1 | $119 |
| Bone Support Inc. | 1 | $113 |
| Acera Surgical, Inc. | 1 | $92 |
| Stryker | 4 | $79 |
| Nuo Therapeutics | 1 | $67 |
| Fidia Pharma USA Inc. | 2 | $65 |
| Hydrofera LLC | 1 | $59 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Stravix$526
- GRAFIX PL$268
- Biovance$250
- Apligraf$140
- TRUELOK SYSTEM$122
- TrueLok$122
- Trinity ELITE$122
- Grafix$119
- GrafixPL$119
- CERAMENTBONE VOID FILLER$113
- CERAMENT G$113
How this compares
$3,424 in reported general payments places this provider in the 85th percentile of 119 podiatrist providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 14 | $17,163 |
| Clotrimazole | 13 | $162 |
| Oxycodone Hcl | 29 | $122 |
| Doxycycline Hyclate | 17 | $110 |
| Mupirocin | 18 | $106 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 31 | $103 |
| Meloxicam | 21 | $71 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Waterbury
- Joel SegalmanWaterbury$3K
- Marc BernbachWaterbury$537
- Peter BlumeNew Haven$481K
- Robert DavisBridgeport$427K
- David NovickiMilford$67K
- Shane ReynoldsNorwalk$14K
- Eric LevineNorwich$12K
- Paul BetschartDanbury$10K
- Michael FeinBethel$9K
- Tehreem SajjadNew Britain$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.